PERC Study
The Impact of Provider-Indentifiable Data on Healthcare Quality and Cost
by Michael Turner, Ph.D., Joseph Duncan, Ph.D., Robin Varghese, Ph.D., and Patrick Walker, M.A.

Executive Summary (PDF)
Full Report (PDF)

PUBLIC POLICY ISSUES IN DTC ADVERTISING
OF PRESCRIPTION DRUGS
John E. Calfee, Ph.D.
American Enterprise Institute
An assessment of the effects of DTC advertising on drug consumption and on health care is provided by Dr. Calfee in an analysis published in Journal of Public Policy and Marketing, Vol. 21 (2), Fall 2002, 174-193. (PDF format)

Independent Study Report
EXPLAINING DRUG SPENDING TRENDS
(Abstract)

THE VALUE OF INCREMENTAL PHARMACEUTICAL INNOVATION
FOR OLDER AMERICANS
by Albert Wertheimer and Thomas W. O'Connor, Jr., Temple University School of Pharmacy, and Richard Levy, National Pharmaceutical Council
This article in monograph form appears on the National Pharmaceutical Council site.

Research Report:
THE ORIGINAL DTC ADVERTISING STUDIES
--A Comparison of Key Findings
Author: Charlotte Sibley
(formerly President, ISIS Research)
Vice President, Marketing, Pharmacia